Xarelto Lawsuits Move Forward Nationwide, with Scheduling of May Conferences in Federal, State Litigations

Share Article

Bernstein Liebhard LLP has filed a number of Xarelto lawsuits in U.S. courts, all of which accuse the drug’s manufacturers of failing to warn of its association with uncontrollable internal bleeding and other serious side effects.

Free Case Review
Our Firm is representing a number of Xarelto lawsuit plaintiffs in U.S. courts, and we are pleased with the progress thus far in the federal and state litigations.

Consolidated ligations established for Xarelto lawsuits (http://www.xareltolawsuit2015.com/) are moving forward nationwide, as courts overseeing proceedings in Louisiana and Pennsylvania prepare to convene conferences next month. According to court documents issued in the U.S. District Court, Eastern District of Louisiana, the next status conference in the federal Xarelto litigation will take place on May 13th at 9:00 a.m. C.S.T. (In Re: Xarelto Products Liability Litigation, No. 2592)

Court records indicate that the Xarelto mass tort litigation underway in Pennsylvania’s Philadelphia Court of Common Pleas will convene its next monthly meeting one week later, on May 20th at 10:00 a.m. E.S.T. (In Re: Xarelto Litigation, Case ID 150102349)

“Our Firm is representing a number of Xarelto lawsuit plaintiffs in U.S. courts, and we are pleased with the progress thus far in the federal and state litigations. We are looking forward to the upcoming conferences in Pennsylvania and Louisiana, as the courts could provide updates regarding the status of discovery, coordination between state and federal proceedings, and other important developments that may prove relevant to our clients cases,” says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective medical devices and drugs. The Firm is currently offering legal consults to individuals who allegedly experienced uncontrollable internal bleeding and other serious Xarelto complications.

Xarelto Litigation
Court documents indicate that more than 600 Xarelto lawsuits have been filed on behalf of individuals who allegedly suffered life-threatening episodes of internal bleeding and other serious side effects while using this blood-thinning medication. This includes just over 400 claims pending in the federal litigation underway in the Eastern District of Louisiana, and 209 cases that have been filed in the mass tort program underway in Pennsylvania. Both of these consolidated litigations were established to allow similar product liability claims involving Xarelto to undergo coordinated pretrial proceedings, thereby conserving the resources of the courts, parties and witnesses.

According to court records, all of the Xarelto lawsuits pending in these two proceedings accuse the manufacturers of the blood-thinning medication of failing to warn the public of its alleged association with uncontrollable internal bleeding and other life-threatening complications, including stroke, deep vein thrombosis, and pulmonary embolism. They also allege that Xarelto was misleadingly marketed as a superior alternative to warfarin, and point out that hemorrhaging caused by this older blood thinner can be stopped via the administration of vitamin K. By contrast, there currently exists no approved antidote to reverse Xarelto bleeding.

Individuals who allegedly experienced internal bleeding and other complications related to Xarelto may be entitled to compensation for medical bills and other damages related to their injuries. Learn more about filing a Xarelto lawsuit by visiting Bernstein Liebhard LLP’s website, or by calling 800-511-5092 to schedule a free, no obligation case review.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The National Law Journal has recognized Bernstein Liebhard for twelve consecutive years as one of the top plaintiffs' firms in the country. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
info (at)consumerinjurylawyers(dot)com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sandy A. Liebhard
Follow us on
Visit website